Abstract
Objectives
Aims of the study were 1) to investigate the association of C-reactive protein (CRP) with lipid (i.e. total, LDL, and HDL cholesterol, triglycerides) concentrations, and to evaluate their predictive value for mortality in very old subjects.
Design
Cross-sectional and longitudinal analyses in a prospective cohort study.
Setting
Participants. Data are from 336 community-dwelling subjects aged ≥80 years old enrolled in the “Invecchiamento e Longevità nel Sirente” (ilSIRENTE) study.
Measurements
High sensitivity CRP and lipid concentrations were measured at the baseline clinical visit. High sensitivity CRP concentrations were measured by ELISA assessment. Mortality outcome was evaluated over a 24-month follow-up.
Results
Participants had a mean age of 85.8 (SD 4.8) years old. Spearman’s correlations showed significant (p values <0.01) inverse correlations between CRP and lipid parameters (except triglycerides). Adjusted linear regressions between CRP and lipid parameters concentrations showed no significant association in participants aged lower than 85 years old (all p values >0.5). In the older age group, significant inverse associations of CRP with total (p=0.002), LDL (p=0.007), and HDL cholesterol (p=0.002) were found, even after adjustment for potential confounders. Adjusted Cox proportional hazard models demonstrated that CRP was the only biomarker significantly predictive of mortality, independently of age and lipid parameters.
Conclusion
An inverse relationship of total, LDL, and HDL cholesterol with CRP is present in very old persons. The prognostic value of CRP is particularly important among very old persons whereas lipid parameters tend to lose their capacity to predict events.
Similar content being viewed by others
References
Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol 1994; 49(6):M252–M257.
Lowe GD. Circulating inflammatory markers and risks of cardiovascular and noncardiovascular disease. J Thromb Haemost 2005; 3:1618–1627.
Cesari M, Penninx BWJH, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108(19):2317–2322.
Reuben DB, Cheh AI, Harris TB, Ferrucci L, Rowe JW, Tracy RP et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002; 50:638–644.
Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003; 114(3):180–187.
Ferrucci L, Harris TB, Guralnik JM, Wacholder S, Tracy RP, Corti MC et al. Inflammation, a novel risk factor for disability in older persons. J Am Geriatr Soc 1999; 47:639–646.
Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BWJH, Lenchik L et al. Sarcopenia, obesity and inflammation — Results from the TRAIN study. Am J Clin Nutr 2005; 82:428–434.
Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006; 119(6):526.e9–526.e17.
Abbott RD, Yano K, Hakim AA, Burchfiel CM, Sharp DS, Rodriguez BL et al. Changes in total and high-density lipoprotein cholesterol over 10- and 20-year periods (The Honolulu Heart Program). Am J Cardiol 1998; 82:172–178.
Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004; 45(7):1169–1196.
Simons LA, Simons J, Friedlander Y, McCallum J. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years. Atherosclerosis 2001; 159(1):201–208.
Casiglia E, Palatini P. Cardiovascular risk factors in the elderly. J Hum Hypertens 1998; 12(9):575–581.
Landi F, Russo A, Cesari M, Barillaro C, Onder G, Zamboni V et al. The ilSIRENTE study: a prospective cohort study on persons aged 80 years and older living in a mountain community of Central Italy. Aging Clin Exp Res 2005; 17(6):486–493.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice: a statement for healthcare professionals from the Center for Disease Control and Prevention and the American Heart Association. Circulation 2003; 177:499–511.
Morris JN, Fries BE, Bernabei R, Ikegami N, Gilgen R, Steel K et al. RAI — Home Care assessment manual. Washington, DC: InterRAI Coporation, 1996.
Hawes C, Morris JN, Phillips CD, Mor V, Fries BE, Nonemaker S. Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS). Gerontologist 1995; 35(2):172–178.
Landi F, Tua E, Onder G, Carrara B, Sgadari A, Rinaldi C et al. Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med Care 2000; 38(12):1184–1190.
Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris TB et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 2000; 48:1618–1625.
Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P. Drug data coding and analysis in epidemiologic studies. Eur J Clin Epidemiol 1994; 10:405–411.
Zuliani G, Volpato S, Ble’ A, Bandinelli S, Corsi AM, Lauretani F et al. High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: The InChianti study. Atherosclerosis 2007; in press.
Ferrara A, Barrett-Connor E, Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984–1994. Circulation 1997; 96:37–43.
Volpato S, Zuliani G, Guralnik JM, Palmieri E, Fellin R, for the Gruppo Italiano di Farmacovigilanza nell’Anziano. The inverse association between age and cholesterol level among older patients: the role of poor health status. Gerontology 2001; 47:36–45.
Volpato S, Palmieri E, Fellin R, Zuliani G. Acute phase markers are associated with reduced plasma lipid levels in a population of hospitalized elderly patients. Gerontology 2000; 46(22):27.
Spieker LE, Ruschitzka F, Luscher TF, Noll G. HDL and inflammation in atherosclerosis. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4(1):51–57.
Ansell BJ, Fonarow GC, Fogelman AM. High-density lipoprotein: is it always atheroprotective? Curr Atheroscler Rep 2006; 8(5):405–411.
Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM. Mechanisms of disease: proatherogenic HDL — An evolving field. Nat Clin Pract Endocrinol Metab 2006; 2(9):504–511.
Ferrucci L, Ble’ A, Bandinelli S, Lauretani F, Suthers K, Guralnik JM. A flame burning within. Aging Clin Exp Res 2004; 16(3):240–243.
Lehtimäki T, Ojala P, Rontu R, Goebeler S, Karhunen PJ, Jylh modulates plasma cholesterol and C-reactive protein concentrations in nonagenarians. J Am Geriatr Soc 2005; 53:1552–1558.
Kronmal RA, Cain KC, Ye Z, Ommen GS. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med 1993; 153:1065–1073.
Newschaffer CJ, Bush TL, Hale WE. Aging and total cholesterol levels: cohort, period, and survivorship effects. Am J Epidemiol 1992; 136:23–24.
Hu P, Seeman TE, Harris TB, Reuben DB. Does inflammation or undernutrition explain the low cholesterol-mortality association in high-functioning older persons? MacArthur Studies of Successful Aging. J Am Geriatr Soc 2004; 51(1):80–84.
Karlamangla AS, Singer BH, Reuben DB, Seeman TE. Increases in serum non-highdensity lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur Studies of Successful Aging. J Am Geriatr Soc 2004; 52(4):487–494.
Krumholz HM, Seeman TE, Merrill SS, Mendes de Leon CF, Vaccarino V, Silverman DI et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 1994; 272(17):1135–1140.
Franceschi C, Bonafe’ M, Valensin S, Olivieri F, De Luca M, Ottaviani E et al. Inflamm-aging — An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908:244–254.
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135–1143
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cesari, M., Onder, G., Zamboni, V. et al. C-Reactive protein and lipid parameters in older persons aged 80 years and older. J Nutr Health Aging 13, 587–594 (2009). https://doi.org/10.1007/s12603-009-0168-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-009-0168-9